Drug-eluting bead transarterial chemoembolization treatment of liver-dominant metastatic leiomyosarcoma

Key Points

• Improved tumor control observed in liver-dominant metastatic leiomyosarcoma patients.
• Key evidence includes significant tumor size reduction noted in 75% of treated cases.
• Observational analysis assessed treatment outcomes in patients receiving drug-eluting bead therapy.
• Findings support drug-eluting bead transarterial chemoembolization as a viable option for liver tumors.